[HTML][HTML] Cyclic peptides in pipeline: what future for these great molecules?

L Costa, E Sousa, C Fernandes - Pharmaceuticals, 2023 - mdpi.com
Cyclic peptides are molecules that are already used as drugs in therapies approved for
various pharmacological activities, for example, as antibiotics, antifungals, anticancer, and …

[HTML][HTML] Challenges in ARDS definition, management, and identification of effective personalized therapies

D Battaglini, B Fazzini, PL Silva, FF Cruz, L Ball… - Journal of Clinical …, 2023 - mdpi.com
Over the last decade, the management of acute respiratory distress syndrome (ARDS) has
made considerable progress both regarding supportive and pharmacologic therapies. Lung …

[HTML][HTML] The epithelial sodium channel—An underestimated drug target

R Lemmens-Gruber, S Tzotzos - International Journal of Molecular …, 2023 - mdpi.com
Epithelial sodium channels (ENaC) are part of a complex network of interacting biochemical
pathways and as such are involved in several disease states. Dependent on site and type of …

[HTML][HTML] Dichotomous role of tumor necrosis factor in pulmonary barrier function and alveolar fluid clearance

R Lucas, Y Hadizamani, P Enkhbaatar… - Frontiers in …, 2022 - frontiersin.org
Alveolar-capillary leak is a hallmark of the acute respiratory distress syndrome (ARDS), a
potentially lethal complication of severe sepsis, trauma and pneumonia, including COVID …

[HTML][HTML] Pneumolysin as a target for new therapies against pneumococcal infections: A systematic review

MD Cima Cabal, F Molina, JI López-Sánchez… - Plos one, 2023 - journals.plos.org
Background This systematic review evaluates pneumolysin (PLY) as a target for new
treatments against pneumococcal infections. Pneumolysin is one of the main virulence …

Investigational pharmacological agents for the treatment of ARDS

K Aribindi, M Lim, S Lakshminrusimha… - Expert Opinion on …, 2024 - Taylor & Francis
ABSTRACT Introduction Acute Respiratory Distress Syndrome (ARDS) is a heterogeneous
form of lung injury with severe hypoxemia and bilateral infiltrates after an inciting event that …

[HTML][HTML] Impact of GAMP 5, data integrity and QbD on quality assurance in the pharmaceutical industry: How obvious is it?

F Pedro, F Veiga, F Mascarenhas-Melo - Drug Discovery Today, 2023 - Elsevier
In the pharmaceutical industry, it is essential to ensure the safety and efficacy of medicinal
products. Therefore a robust quality assurance framework is needed. This manuscript …

Treatment for acute respiratory distress syndrome in adults: a narrative review of phase 2 and 3 trials

D Battaglini, C Robba, P Pelosi… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Ventilatory management and general supportive care of acute respiratory
distress syndrome (ARDS) in the adult population have led to significant clinical …

An update on the pharmacological management of acute respiratory distress syndrome

D Battaglini, IG Iavarone… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Acute respiratory distress syndrome (ARDS) is characterized by acute
inflammatory injury to the lungs, alterations in vascular permeability, loss of aerated tissue …

[HTML][HTML] Therapeutic polypeptides and peptidomimetics: powerful tools for COVID-19 treatment

X Liu, J Shi, D Wang, Y Su, Z Xing, F Sun… - Clinical Drug …, 2023 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic has swept the whole world
and brought about a public health crisis of unprecedented proportions. To combat the rapid …